Slc34a1 - solute carrier family 34 (sodium phosphate), member 1 Gene
Also Known as Npt2; Npt2a; Slc17a2; NaPi-IIa
Species: Mus musculus
Summary
Predicted to enable PDZ domain binding activity; identical protein binding activity; and sodium:phosphate symporter activity. Acts upstream of or within bone remodeling. Located in basolateral plasma membrane and vesicle. Is expressed in genitourinary system; ileum; skeleton; and tooth. Used to study hereditary hypophosphatemic rickets with hypercalciuria. Human ortholog(s) of this gene implicated in several diseases, including Fanconi syndrome (multiple); chronic kidney disease; hereditary hypophosphatemic rickets with hypercalciuria; hypophosphatemic nephrolithiasis/osteoporosis 1; and nephrolithiasis. Orthologous to human SLC34A1 (solute carrier family 34 member 1). [provided by Alliance of Genome Resources, Apr 2022]
Slc34a1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_011392.2 | NP_035522.2 | sodium-dependent phosphate transport protein 2A |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
sodium-dependent phosphate transport protein 2A |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-112065 | PF-06869206 | Inhibitor | 99.88% | Unkown |
| HY-RS13192 | SLC34A1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service